JAN 26, 2016 11:03 AM PST

Protective Autophagy in Regulatory T Cells

WRITTEN BY: Kara Marker
Acting alongside T helper cells, the all-stars of adaptive immunity, regulatory T cells work to suppress any “potentially deleterious” T helper cell activities that could lead to an autoimmune disorder (Scandinavian Journal of Immunology). T helper cells activate effector immune cells to attack invading pathogens and abnormally growing cells, which is a good thing. However, these lymphocytes can also make mistakes and wrongly target the body’s own cells. This is where regulatory T cells come into play, protecting the body by maintaining self-tolerance and preventing allergic responses.
 
With regulatory T cells at the ready to keep the body’s immune system from attacking itself, other immune cells are free to concentrate on attacking pathogens and killing cancerous cells. However, what happens when the regulatory T cells themselves need protecting?
 
A regulatory T cell (blue) interacting with bacteria (green)

A new study published in Nature Immunology by scientists from St. Jude Children’s Research Hospital investigated the protective mechanisms of regulatory T cells. Like a doctor who helps treat and prevent other people from getting sick, regulatory T cells also depend on certain cellular processes to continue normal function, similar to how doctors wear masks, gloves, and wash their hands when with a patient.
 
"Regulatory T cells are very specialized cells that require activation to perform their function in curtailing undesirable immune responses," said study leader Hongbo Chi, PhD.
 
After being activated, a process called “autophagy” relieves regulatory T cells of “molecular garbage” that piles up in the cell. Imaging studies done from colon cancer cells in Chi’s experiments proved the necessity of autophagy for regulatory T cell function. Next, the team looked at mice models of disease to see how organisms respond as a whole when the process of autophagy was disturbed. Key genes for autophagy, Atg5 and Atg7, were deleted, and they saw regulatory T cell malfunction as expected in these knock-out mice.
 
Activated regulatory T cells without functional autophagy experienced excessive cell death and a “loss of identity,” a phrase Chi used to describe their non-regulatory T cell action that occurred without autophagy. Thus, after losing their traditional abilities and gaining new ones, the regulatory T cell population in the knock-out mice were actually able to clear tumors better than control mice.
 
"From this perspective, targeting autophagy could act in synergy with strategies that block autophagy in tumor cells for added benefits in cancer therapy," Chi said.
 
He and his team plan to study other tumor cell types with autophagy inhibition in regulatory T cells, focusing on the “detailed biochemical mechanisms” behind the protective mechanism of autophagy for regulatory T cells. The potential for new immunotherapies for cancer to be derived from this research is great, but Chi and his team have to ensure that upsetting the protective function of regulatory T cells does not create dangerous backlash for cancer patients.
 

Source: St. Jude Children’s Research Hospital
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 09, 2018
Immunology
OCT 09, 2018
Complement Function Expands
Additional roles to complement protein C3 have been described in work performed by a team of researchers at the Lund University in Sweden...
NOV 07, 2018
Drug Discovery
NOV 07, 2018
Modifying Antibiotics For Drug Resistant Infections
In a study published in Nature Chemistry, researches at MIT were able to create a new chemical reaction that has the ability to modify antibiotics to make ...
NOV 07, 2018
Immunology
NOV 07, 2018
Is Your Brain Asking for High Blood Pressure?
Study finds that the brain is sending signals to the bone marrow to increase blood pressure....
NOV 12, 2018
Health & Medicine
NOV 12, 2018
Researchers find that obesity has a paradoxical effect on Cancer
Cancer therapy works differently in different people. Understanding what effects the individual body's response to treatment will be crucial for the development...
NOV 15, 2018
Drug Discovery
NOV 15, 2018
Anti-inflammatory Drug Works Like an Inhibitor
At Karolinska Institutet in Sweden, a team of scientists from multiple disciplines have worked together to develop an inflammation inhibitor. The new anti-...
DEC 05, 2018
Immunology
DEC 05, 2018
Combo-Kick to Battle Lymphoma
Combination immunotherapy has provided remission for patients suffering from Hodgkin's Lymphoma...
Loading Comments...